Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise

NCT: NCT07226583 · NOT_YET_RECRUITING

NCT IDNCT07226583
StatusNOT_YET_RECRUITING
Start Date2026-04
Completion2026-08

Brief Summary

This study evaluates a clinician-facing decision-support toolkit designed to assist adults with type 1 diabetes in preparing for moderate-intensity exercise. The netIOB \& Exercise Toolkit (NEXT) integrates recent glucose data and insulin delivery history to provide individualized suggestions regarding exercise timing, insulin adjustments, and carbohydrate intake. Adults with type 1 diabetes will complete three supervised exercise sessions under different pre-exercise guidance approaches: (A) published consensus-based standard-of-care guidance, (B) usual personal care routines, and (C) guidance informed by the NEXT Toolkit. A healthy adult control group will complete a single supervised exercise session to provide comparative physiologic data.

Frequently Asked Questions

What is Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise?

Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise is a clinical trial registered under NCT07226583. Current status: NOT_YET_RECRUITING.

What is the status of NCT07226583?

The current status of NCT07226583 (Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise) is: NOT_YET_RECRUITING.

When did Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise start?

Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise started on 2026-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.